Elisabet
Guruceaga Martínez

Bioinformática

Foto de Elisabet

Foto de Alfonso

Alfonso
Calvo González

Catedrático de Universidad

Publications by the researcher in collaboration with Alfonso Calvo González (7)

2024

Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation
Molecular Cancer, Vol. 23, Núm. 1

2020

Id1 and pd-1 combined blockade impairs tumor growth and survival of KRAS-mutant lung cancer by stimulating PD-l1 expression and tumor infiltrating CD8+ T cells
Cancers, Vol. 12, Núm. 11, pp. 1-22

2019

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1
Scientific Reports, Vol. 9, Núm. 1
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001
Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery
Cancer Letters, Vol. 453, pp. 21-33

2014

Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma
PLoS ONE, Vol. 9, Núm. 1

2010

Molecular characterization of the Gγ-globin-tagtransgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer
Prostate, Vol. 70, Núm. 6, pp. 630-645